MCGRATH DENNIS M
SEC insider (Form 3/4/5 filer). CIK 0001269340. Director at DarioHealth Corp. (DRIO) and 4 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies MCGRATH DENNIS M has filed insider reports for
- DarioHealth Corp. (DRIO): Director
- PAVmed Inc. (PAVM): Officer, President and CFO
- Lucid Diagnostics Inc. (LUCD): Officer, Chief Financial Officer
- CITIUS ONCOLOGY, INC. (CTOR): Director
- Citius Pharmaceuticals, Inc. (CTXR): Director
MCGRATH DENNIS M
CIK: 0001269340
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 24, 2026DRIO
DarioHealth Corp.
AwardDirect61K shares- - Apr 2, 2026PAVM
PAVmed Inc.
AwardDirect180K shares- - Feb 20, 2026LUCD
Lucid Diagnostics Inc.
AwardDirect470K shares- - Sep 30, 2025PAVM
PAVmed Inc.
AwardDirect150K shares- - Sep 19, 2025CTOR
CITIUS ONCOLOGY, INC.
AwardDirect300K shares- - Sep 11, 2025DRIO
DarioHealth Corp.
AwardDirect20K shares- - Feb 20, 2025LUCD
Lucid Diagnostics Inc.
AwardDirect300K shares- - Dec 12, 2024CTOR
CITIUS ONCOLOGY, INC.
AwardDirectStock Option (Right to Buy)
125K shares- - Nov 7, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Purchase Common Stock)
125K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  DRIO DarioHealth Corp. | Award | 61,000 | - | $0 | Direct |
| Apr 2, 2026 |  PAVM PAVmed Inc. | Award | 180,000 | - | $0 | Direct |
| Feb 20, 2026 |  LUCD Lucid Diagnostics Inc. | Award | 470,000 | - | $0 | Direct |
| Sep 30, 2025 | PAVM PAVmed Inc. | Award | 150,000 | - | - | Direct |
| Sep 19, 2025 |  CTOR CITIUS ONCOLOGY, INC. | Award | 300,000 | - | - | Direct |
| Sep 11, 2025 | DRIO DarioHealth Corp. | Award | 20,000 | - | - | Direct |
| Feb 20, 2025 | LUCD Lucid Diagnostics Inc. | Award | 300,000 | - | - | Direct |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | Award Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Nov 7, 2024 |  CTXR Citius Pharmaceuticals, Inc. | Award Stock Option (Right to Purchase Common Stock) | 125,000 | - | - | Direct |
1-9 of 9 transactions